ELEVATE TN: Acalabrutinib ± Obinutuzumab vs Obinutuzumab + Chlorambucil in Treatment-Naive CLL

December 7-10, 2019; Orlando, Florida
Acalabrutinib with or without obinutuzumab significantly improved PFS compared with obinutuzumab plus chlorambucil.
Format: Microsoft PowerPoint (.ppt)
File Size: 208 KB
Released: December 11, 2019


Provided by the Annenberg Center for Health Sciences at Eisenhower in partnership with Clinical Care Options.

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Celgene Corporation
Dova Pharmaceuticals, Inc.
Karyopharm Therapeutics
Loxo Oncology, Inc. a wholly owned subsidiary of Eli Lilly and Company
Pharmacyclics LLC, an AbbVie Company
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Related Content

From Clinical Care Options (CCO), download a PDF featuring expert answers to clinician questions on CAR T-cell therapy

person default Caron A. Jacobson, MD Jae H. Park, MD Noopur Raje, MD Released: July 19, 2021

Drs George Follows, Paolo Ghia, Veronique Leblond discuss the latest clinical data on BTK inhibitors for the treatment of CLL from Clinical Care Options (CCO)

George Follows, BM, BCh, PhD Paolo Ghia, MD, PhD Veronique Leblond, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: July 19, 2021 Expired: July 18, 2022

Downloadable slideset with highlights from key blood cancers and nonmalignant blood disorders as presented at EHA Virtual Congress 2021, from Clinical Care Options (CCO)

Prof. Charles Craddock, CBE, FRCP (UK) María-Victoria Mateos, MD, PhD Lydia Scarfò, MD Ali T. Taher, MD, PhD Released: July 16, 2021

Interactive online tool with expert and guideline recommendations for assessing and managing CAR T-cell toxicities, from Clinical Care Options (CCO)

Alix Beaupierre, BSN, RN, OCN Daniel J. DeAngelo, MD, PhD Matthew J. Frigault, MD Shilpa Paul Headshot Shilpa Paul, PharmD, BCOP Noopur Raje, MD Released: July 9, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.